IDEXX LABORATORIES INC /DE Revenue, Net (Deprecated 2018-01-31)
IDEXX LABORATORIES INC /DE (IDXX) reported Revenue, Net (Deprecated 2018-01-31) of $506.12 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-02-16
- IDEXX LABORATORIES INC /DE revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $506.12M, a 14.25% increase year-over-year.
- IDEXX LABORATORIES INC /DE revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $491.98M, a 9.74% increase year-over-year.
- IDEXX LABORATORIES INC /DE revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $508.94M, a 9.08% increase year-over-year.
- IDEXX LABORATORIES INC /DE revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $462.02M, a 10.65% increase year-over-year.
- IDEXX LABORATORIES INC /DE revenue, net (deprecated 2018-01-31) for fiscal 2017 was $1.97B, a 10.91% increase from fiscal 2016.
- IDEXX LABORATORIES INC /DE revenue, net (deprecated 2018-01-31) for fiscal 2016 was $1.78B, a 10.83% increase from fiscal 2015.
- IDEXX LABORATORIES INC /DE revenue, net (deprecated 2018-01-31) for fiscal 2015 was $1.60B, a 7.81% increase from fiscal 2014.
- IDEXX LABORATORIES INC /DE revenue, net (deprecated 2018-01-31) for fiscal 2014 was $1.49B, a 7.90% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $506.12M 10-K · filed 2018-02-16 | $998.10M derived: sum of 2 quarters · filed 2018-02-16 | $1.51B derived: sum of 3 quarters · filed 2018-02-16 | $1.97B 10-K · filed 2018-02-16 |
| 2017-09-30 | $491.98M 10-K · filed 2018-02-16 | $1.00B derived: sum of 2 quarters · filed 2018-02-16 | $1.46B 10-Q · filed 2017-10-31 | $1.91B derived: sum of 4 quarters · filed 2018-02-16 |
| 2017-06-30 | $508.94M 10-K · filed 2018-02-16 | $970.96M 10-Q · filed 2017-08-01 | $1.41B derived: sum of 3 quarters · filed 2018-02-16 | $1.86B derived: sum of 4 quarters · filed 2018-02-16 |
| 2017-03-31 | $462.02M 10-K · filed 2018-02-16 | $905.02M derived: sum of 2 quarters · filed 2018-02-16 | $1.35B derived: sum of 3 quarters · filed 2018-02-16 | $1.82B derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-12-31 | $443.00M 10-K · filed 2018-02-16 | $891.30M derived: sum of 2 quarters · filed 2018-02-16 | $1.36B derived: sum of 3 quarters · filed 2018-02-16 | $1.78B 10-K · filed 2018-02-16 |
| 2016-09-30 | $448.31M 10-K · filed 2018-02-16 | $914.88M derived: sum of 2 quarters · filed 2018-02-16 | $1.33B 10-Q · filed 2017-10-31 | $1.73B derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $466.57M 10-K · filed 2018-02-16 | $884.12M 10-Q · filed 2017-08-01 | $1.28B derived: sum of 3 quarters · filed 2018-02-16 | $1.69B derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $417.55M 10-K · filed 2018-02-16 | $817.24M derived: sum of 2 quarters · filed 2018-02-16 | $1.22B derived: sum of 3 quarters · filed 2018-02-16 | $1.64B derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $399.69M 10-K · filed 2017-02-17 | $806.07M derived: sum of 2 quarters · filed 2017-02-17 | $1.22B derived: sum of 3 quarters · filed 2017-02-17 | $1.60B 10-K · filed 2018-02-16 |
| 2015-09-30 | $406.39M 10-K · filed 2017-02-17 | $819.73M derived: sum of 2 quarters · filed 2017-02-17 | $1.20B 10-Q · filed 2016-11-01 | $1.55B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $413.34M 10-K · filed 2017-02-17 | $795.82M 10-Q · filed 2016-08-02 | $1.15B derived: sum of 3 quarters · filed 2017-02-17 | $1.53B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $382.48M 10-K · filed 2017-02-17 | $734.44M derived: sum of 2 quarters · filed 2017-02-17 | $1.12B derived: sum of 3 quarters · filed 2017-02-17 | $1.51B derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $351.96M 10-K · filed 2016-02-17 | $735.48M derived: sum of 2 quarters · filed 2016-02-17 | $1.13B derived: sum of 3 quarters · filed 2016-02-17 | $1.49B 10-K · filed 2017-02-17 |
| 2014-09-30 | $383.52M 10-K · filed 2016-02-17 | $773.64M derived: sum of 2 quarters · filed 2016-02-17 | $1.13B 10-Q · filed 2015-10-28 | $1.49B derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $390.12M 10-K · filed 2016-02-17 | $750.33M 10-Q · filed 2015-07-30 | $1.10B derived: sum of 3 quarters · filed 2016-02-17 | $1.44B derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $360.20M 10-K · filed 2016-02-17 | $714.28M derived: sum of 2 quarters · filed 2016-02-17 | $1.05B derived: sum of 3 quarters · filed 2016-02-17 | $1.41B derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $354.07M 10-K · filed 2015-02-17 | $692.37M derived: sum of 2 quarters · filed 2015-02-17 | $1.04B derived: sum of 3 quarters · filed 2015-02-17 | $1.38B 10-K · filed 2016-02-17 |
| 2013-09-30 | $338.30M 10-K · filed 2015-02-17 | $690.88M derived: sum of 2 quarters · filed 2015-02-17 | $1.02B 10-Q · filed 2014-10-24 | $1.34B derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $352.58M 10-K · filed 2015-02-17 | $684.69M 10-Q · filed 2014-07-25 | $1.00B derived: sum of 3 quarters · filed 2015-02-17 | $1.32B derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $332.11M 10-K · filed 2015-02-17 | $651.64M derived: sum of 2 quarters · filed 2015-02-17 | $967.12M derived: sum of 3 quarters · filed 2015-02-17 | $1.30B derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $319.54M 10-K · filed 2014-02-18 | $635.01M derived: sum of 2 quarters · filed 2014-02-18 | $970.66M derived: sum of 3 quarters · filed 2014-02-18 | $1.29B 10-K · filed 2015-02-17 |
| 2012-09-30 | $315.48M 10-K · filed 2014-02-18 | $651.12M derived: sum of 2 quarters · filed 2014-02-18 | $973.80M 10-Q · filed 2013-10-22 | $1.28B derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $335.65M 10-K · filed 2014-02-18 | $658.33M 10-Q · filed 2013-07-23 | $965.53M derived: sum of 3 quarters · filed 2014-02-18 | $1.27B derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $322.68M 10-K · filed 2014-02-18 | $629.88M derived: sum of 2 quarters · filed 2014-02-18 | $930.83M derived: sum of 3 quarters · filed 2014-02-18 | $1.25B derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $307.20M 10-K · filed 2013-02-19 | $608.15M derived: sum of 2 quarters · filed 2013-02-19 | $926.02M derived: sum of 3 quarters · filed 2013-02-19 | $1.22B 10-K · filed 2014-02-18 |
| 2011-09-30 | $300.95M 10-K · filed 2013-02-19 | $618.82M derived: sum of 2 quarters · filed 2013-02-19 | $911.49M 10-Q · filed 2012-10-19 | $1.20B derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $317.86M 10-K · filed 2013-02-19 | $610.53M 10-Q · filed 2012-07-20 | $894.29M derived: sum of 3 quarters · filed 2013-02-19 | $1.16B derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $292.67M 10-K · filed 2013-02-19 | $576.43M derived: sum of 2 quarters · filed 2013-02-19 | $846.06M derived: sum of 3 quarters · filed 2013-02-19 | $1.13B derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $283.76M 10-K · filed 2012-02-17 | $553.38M derived: sum of 2 quarters · filed 2012-02-17 | $834.87M derived: sum of 3 quarters · filed 2012-02-17 | $1.10B 10-K · filed 2013-02-19 |
| 2010-09-30 | $269.63M 10-K · filed 2012-02-17 | $551.11M derived: sum of 2 quarters · filed 2012-02-17 | $819.63M 10-Q · filed 2011-10-21 | $1.09B derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $281.48M 10-K · filed 2012-02-17 | $550.01M 10-Q · filed 2011-07-22 | $820.34M derived: sum of 3 quarters · filed 2012-02-17 | $1.08B derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $268.52M 10-K · filed 2012-02-17 | $538.86M derived: sum of 2 quarters · filed 2012-02-17 | $797.98M derived: sum of 3 quarters · filed 2012-02-17 | $1.06B derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $270.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $529.46M derived: sum of 2 quarters · filed 2012-02-17 | $795.18M derived: sum of 3 quarters · filed 2012-02-17 | $1.03B 10-K · filed 2012-02-17 |
| 2009-09-30 | $259.12M 10-Q · filed 2010-10-22 | $524.84M derived: sum of 2 quarters · filed 2010-10-22 | $761.30M 10-Q · filed 2010-10-22 | |
| 2009-06-30 | $265.72M 10-Q · filed 2010-07-23 | $502.18M 10-Q · filed 2010-07-23 | ||
| 2008-12-31 | $1.02B 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |